Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/ce/b4/9e/ceb49ee3-edfb-d218-63cd-746101f39733/mza_2804619413719298064.jpg/600x600bb.jpg
PeerVoice Immunology & Infectious Disease Video
PeerVoice
74 episodes
2 months ago
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
RSS
All content for PeerVoice Immunology & Infectious Disease Video is the property of PeerVoice and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/ce/b4/9e/ceb49ee3-edfb-d218-63cd-746101f39733/mza_2804619413719298064.jpg/600x600bb.jpg
James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis
PeerVoice Immunology & Infectious Disease Video
19 minutes 34 seconds
7 months ago
James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis
Visit https://www.peervoice.com/DSN860 to view the entire programme with slides. After completing “James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis”, participants will be able to: Explain how the immunological processes underpinning the pathophysiology of generalised myasthenia gravis (gMG) are targeted by the novel mechanisms of action of emerging therapies; Discuss key characteristics of currently available targeted therapies for gMG with particular reference to potential benefits and limitations; and Evaluate how specific patient factors can impact individualised treatment plans.
PeerVoice Immunology & Infectious Disease Video
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.